{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:04:24Z","timestamp":1770836664467,"version":"3.50.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T00:00:00Z","timestamp":1483660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Menarini"},{"name":"Nycomed"},{"name":"Willpharma"},{"name":"Junior Scientific Masterclass MD\/PhD funds of the University Medical Center Groningen"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0169673","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T17:48:44Z","timestamp":1483984124000},"page":"e0169673","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer"],"prefix":"10.1371","volume":"12","author":[{"given":"Ingrid E.","family":"Fakkert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eveline","family":"van der Veer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elske Marije","family":"Abma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joop D.","family":"Lefrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce H. R.","family":"Wolffenbuttel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C.","family":"Oosterwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riemer H. J. A.","family":"Slart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris G.","family":"Westrik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geertruida H.","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian J. E.","family":"Mourits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,1,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"5","author":"A Antoniou","year":"2003","journal-title":"Am.J.Hum.Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10549-010-0805-3","article-title":"Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age","volume":"3","author":"DM van der Kolk","year":"2010","journal-title":"Breast Cancer Res.Treat"},{"key":"ref3","unstructured":"NABON (Nationaal borstkanker overleg Nederland). Breast cancer Dutch guideline Version 2.0. 2012; Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/oncoline.nl\/uploaded\/docs\/mammacarcinoom\/Dutch%20Breast%20Cancer%20Guideline%202012.pdf\" xlink:type=\"simple\">http:\/\/oncoline.nl\/uploaded\/docs\/mammacarcinoom\/Dutch%20Breast%20Cancer%20Guideline%202012.pdf<\/ext-link>."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.maturitas.2011.10.008","article-title":"Model of care for women at increased risk of breast and ovarian cancer","volume":"1","author":"GH De Bock","year":"2012","journal-title":"Maturitas"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2008.12.024","article-title":"A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer","volume":"1","author":"TM Michelsen","year":"2009","journal-title":"Gynecol.Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses&apos; health study","volume":"5","author":"WH Parker","year":"2009","journal-title":"Obstet.Gynecol"},{"key":"ref7","unstructured":"CBO Kwaliteitsinstituut voor de gezondheidszorg, Nederlandse vereniging voor de reumatologie. Richtlijn osteoporose en fractuurpreventie, derde herziening. 2011; Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.diliguide.nl\/document\/1015\/osteoporose-en-fractuurpreventie.html\" xlink:type=\"simple\">http:\/\/www.diliguide.nl\/document\/1015\/osteoporose-en-fractuurpreventie.html<\/ext-link>."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ygyno.2011.04.004","article-title":"Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1\/2 mutation carriers","volume":"2","author":"JS Chapman","year":"2011","journal-title":"Gynecol.Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/bjc.2011.202","article-title":"Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT","volume":"1","author":"J Challberg","year":"2011","journal-title":"Br.J.Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/gme.0b013e318239caeb","article-title":"Surgical menopause and nonvertebral fracture risk among older US women","volume":"5","author":"KK Vesco","year":"2012","journal-title":"Menopause"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejca.2014.11.022","article-title":"Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer","volume":"3","author":"IE Fakkert","year":"2015","journal-title":"Eur.J.Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"2","author":"S Vasikaran","year":"2011","journal-title":"Osteoporos.Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","article-title":"Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study","volume":"8","author":"P Garnero","year":"2000","journal-title":"J.Bone Miner.Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2011.06.033","article-title":"Comparison of the acute alterations in serum bone turnover markers and bone mineral density among women with surgical menopause","volume":"1","author":"S Bahar","year":"2011","journal-title":"Eur.J.Obstet.Gynecol.Reprod.Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0378-5122(95)00940-M","article-title":"The chronological change of vertebral bone loss following oophorectomy using dual energy X-ray absorptiometry: the correlation with specific markers of bone metabolism","volume":"3","author":"K Hashimoto","year":"1995","journal-title":"Maturitas"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.88.12.5134","article-title":"Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells","volume":"12","author":"R Pacifici","year":"1991","journal-title":"Proc.Natl.Acad.Sci.U.S.A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S8756-3282(99)00175-1","article-title":"Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy","volume":"3","author":"P Peris","year":"1999","journal-title":"Bone"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1507\/endocrj.46.337","article-title":"Changes in serum levels of type I collagen-related proteins after surgically induced menopause and correlations with bone loss in the lumbar spine","volume":"2","author":"T Yasumizu","year":"1999","journal-title":"Endocr.J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0378-5122(02)00180-9","article-title":"Bone resorption versus estrogen loss following oophorectomy and menopause","volume":"1","author":"H Ohta","year":"2002","journal-title":"Maturitas"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/gye.15.6.466.471","article-title":"Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women","volume":"6","author":"G Morgante","year":"2001","journal-title":"Gynecol.Endocrinol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00223-003-0054-0","article-title":"Bone turnover markers and PTH levels in surgical versus natural menopause","volume":"2","author":"MA Garcia-Perez","year":"2004","journal-title":"Calcif.Tissue Int"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jsbmb.2011.09.002","article-title":"Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease","volume":"1\u20132","author":"CR Doorenbos","year":"2012","journal-title":"J.Steroid Biochem.Mol.Biol"},{"key":"ref23","first-page":"2180","article-title":"Effective tracing of osteoporosis at a fracture and osteoporosis clinic in Groningen; an analysis of the first 100 patients","volume":"44","author":"JH Hegeman","year":"2004","journal-title":"Ned.Tijdschr.Geneeskd"},{"issue":"Suppl 1","key":"ref24","first-page":"S249","article-title":"Bone Mineral Density reference databases for American men and women","author":"TL Kelly","year":"1990","journal-title":"J Bone Min Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s001980050093","article-title":"Updated data on proximal femur bone mineral levels of US adults","volume":"5","author":"AC Looker","year":"1998","journal-title":"Osteoporos.Int"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00223-008-9126-5","article-title":"Determinants of bone turnover markers in healthy premenopausal women","volume":"5","author":"S Adami","year":"2008","journal-title":"Calcif.Tissue Int"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bone.2010.07.017","article-title":"Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study","volume":"4","author":"MS Ardawi","year":"2010","journal-title":"Bone"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S8756-3282(03)00171-6","article-title":"Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study","volume":"1","author":"E Sornay-Rendu","year":"2003","journal-title":"Bone"},{"key":"ref29","first-page":"414","article-title":"Markers of bone turnover in postmenopausal women receiving hormone replacement therapy","volume":"5","author":"A Hamwi","year":"2001","journal-title":"Clin.Chem.Lab.Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00198-007-0545-3","article-title":"Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women","volume":"8","author":"PD Delmas","year":"2008","journal-title":"Osteoporos.Int"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"f3829","DOI":"10.1136\/bmj.f3829","article-title":"Familial breast cancer: summary of updated NICE guidance","author":"DG Evans","year":"2013","journal-title":"BMJ"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1359\/jbmr.060508","article-title":"Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230)","volume":"8","author":"R Eastell","year":"2006","journal-title":"J.Bone Miner.Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0169673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:46:06Z","timestamp":1540255566000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0169673"}},"subtitle":[],"editor":[{"given":"James J.","family":"Cray","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,6]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0169673","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,6]]}}}